How Does Yusimry Work? Mechanism of Action Explained in Plain English

Yusimry (adalimumab-aqvh) works by targeting a specific protein in your immune system called tumor necrosis factor-alpha (TNF-alpha). Understanding how this works helps explain why Yusimry is effective for so many different autoimmune conditions — and why it carries certain risks.

What Is TNF-Alpha?

Tumor necrosis factor-alpha (TNF-alpha) is a naturally occurring protein (called a cytokine) produced by your immune system. In healthy individuals, TNF-alpha plays an important role in regulating immune responses — helping the body fight infections and coordinate inflammatory signals when needed.

But in autoimmune conditions like rheumatoid arthritis, Crohn's disease, and plaque psoriasis, the immune system goes haywire and produces too much TNF-alpha. This excess TNF-alpha drives chronic inflammation — attacking the body's own joints, gut, skin, or other tissues and causing pain, damage, and symptoms.

How Does Yusimry Block TNF-Alpha?

Yusimry is a monoclonal antibody — a type of protein engineered in a laboratory to precisely target and bind to TNF-alpha. Think of it like a specialized "lock and key" system: Yusimry is shaped to fit exactly onto TNF-alpha, grabbing onto it and preventing it from connecting with TNF receptors on cell surfaces.

Specifically, according to the prescribing information, adalimumab products (including Yusimry):

Bind specifically to TNF-alpha and block its interaction with the p55 and p75 cell surface TNF receptors

Can lyse (destroy) surface TNF-expressing cells in the presence of complement

Do NOT bind or inactivate lymphotoxin (TNF-beta), another related cytokine — so its blocking effect is specific to TNF-alpha

Why Does Blocking TNF-Alpha Help?

When TNF-alpha is blocked by Yusimry, the downstream cascade of inflammation is interrupted. For example:

In rheumatoid arthritis: Elevated TNF-alpha levels in synovial fluid (the fluid in joints) drive joint inflammation and damage. By blocking TNF-alpha, Yusimry reduces joint swelling, pain, and the structural damage that leads to disability.

In Crohn's disease and ulcerative colitis: TNF-alpha fuels the gut inflammation that causes abdominal pain, diarrhea, and intestinal damage. Blocking it reduces gut inflammation and induces remission.

In plaque psoriasis: TNF-alpha drives the overproduction of skin cells that causes the thick, scaly plaques. Blocking TNF-alpha slows skin cell turnover and reduces inflammation.

What Kind of Drug Is Yusimry? (Drug Class)

Yusimry belongs to the following drug classes:

TNF-alpha inhibitor (also called TNF blocker or anti-TNF)

Monoclonal antibody — a biological molecule engineered to target a specific protein

Biologic DMARD (disease-modifying antirheumatic drug) — it modifies the underlying disease process rather than just treating symptoms

Yusimry is not a traditional small-molecule drug (like ibuprofen or metformin) and does not work the same way as steroids. It's a large protein molecule that must be injected — it cannot be taken as a pill because digestive enzymes would break it down before it could work.

Why Does Blocking TNF-Alpha Also Increase Infection Risk?

TNF-alpha isn't just a troublemaker — it also plays a critical role in your body's defense against infections, particularly tuberculosis and certain fungal infections. When Yusimry suppresses TNF-alpha, it blunts this protective immune function, making you more vulnerable to infections that a healthy immune system would normally contain. This is why Yusimry requires a TB test before starting and carries a black box warning for serious infections.

For a broader overview of Yusimry uses and dosing, see What Is Yusimry?. If you need help finding Yusimry at a pharmacy, medfinder can help.